Table 4.
Sensitivity analyses to assess the robustness of the association between number of dissected lymph nodes and Recurrence-free survival
| Number of lymph nodes examined | No. patients | No. events | Adjusted model * | |
|---|---|---|---|---|
| Hazard ratio (95% confidence interval) | P value | |||
| Fewer than 9 a | 51 | 20 | 1.00 (reference) | |
| At least 9 a | 407 | 98 | 0.43 (0.26, 0.73) | 0.002 |
| Fewer than 9 b | 51 | 20 | 1.00 (reference) | |
| At least 9 b | 407 | 98 | 0.45 (0.27, 0.77) | 0.003 |
a Recounted the number of lymph nodes of single station which higher than 5 to 5
b Death without recurrence was considered competing events for recurrence-free survival
* Adjusted for age, sex, age-adjusted Charlson Comorbidity Index, surgical year, tumor site, family history of malignancy, histopathological subtype, spread through air space, pT, pN and postoperative adjuvant therapy